Literature DB >> 29435078

Gene expression analyses associated with malignant phenotypes of metastatic sub-clones derived from a mouse oral squamous cell carcinoma Sq-1979 cell line.

Mitsutaka Adachi1,2, Masako Mizuno-Kamiya1,3, Eiji Takayama1, Harumi Kawaki1, Toshihiro Inagaki1,4, Shigeki Sumi1,2, Masayuki Motohashi2, Yasunori Muramatsu2, Shin-Ichiro Sumitomo2, Michio Shikimori5, Yutaka Yamazaki6, Nobuo Kondoh1.   

Abstract

To elucidate the genetic events that occur during the development of OSCC, the present study established a model of oral malignancy using a mouse oral squamous cell carcinoma (OSCC) Sq-1979 cell line. Sq-1979 cells were implanted into syngeneic C3H mice. Subsequently, 233 cells and metastatic sub-clones (L cells) from primary OSCC, as well as the metastasized lymph node tissues of Sq-1979-implanted mice were established. Compared with parental Sq-1979 and 233 cells, the majority of L cells exhibited a higher proliferation rate and transplantability, and conferred a lower survival rate on the implanted mice. To investigate the genetic background of L cells, preferentially expressed genes in L cells were identified by cDNA microarray and reverse transcription-polymerase chain reaction analyses. The expression of FYN-binding protein (Fyb), solute carrier family 16 member 13 (Slc16a13), keratin 7, transmembrane portion 173 and Slc44a3 mRNAs was significantly elevated in L cells compared with that in Sq1979 and 233 cells. The mRNA expression was also evaluated in human OSCC and leukoplakia (LP) tissues. Among the 5 aforementioned mRNAs, the expression of FYB and SLC16A13 was significantly higher in OSCC than in LP tissues. Furthermore, the expression of SLC16A13 mRNA was significantly elevated in highly invasive OSCCs, which were classified as grades 3 and 4 by the Yamamoto-Kohama (YK) classification of invasion, compared with those in lower grades (YK-1 and -2). The model proposed in the present study could thus describe essential marker genes for the diagnosis of oral malignancies.

Entities:  

Keywords:  C3H/HeN mice; FYN-binding protein; Sq1979 cells; oral squamous cell carcinoma; reverse transcription-quantitative polymerase chain reaction; solute carrier family 16 member 13

Year:  2017        PMID: 29435078      PMCID: PMC5778895          DOI: 10.3892/ol.2017.7648

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  23 in total

1.  Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors.

Authors:  Ann H Klopp; Yan Zhang; Travis Solley; Felipe Amaya-Manzanares; Frank Marini; Michael Andreeff; Bisrat Debeb; Wendy Woodward; Rosemarie Schmandt; Russell Broaddus; Karen Lu; Mikhail G Kolonin
Journal:  Clin Cancer Res       Date:  2011-12-13       Impact factor: 12.531

2.  Expression of Fyn kinase modulates EMT in oral cancer cells.

Authors:  Ben Lewin; Amanda Siu; Cameron Baker; Dongmin Dang; Rebecca Schnitt; Pedram Eisapooran; Daniel M Ramos
Journal:  Anticancer Res       Date:  2010-07       Impact factor: 2.480

3.  Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production.

Authors:  A J da Silva; Z Li; C de Vera; E Canto; P Findell; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

4.  Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico.

Authors:  Amy L Williams; Suzanne B R Jacobs; Hortensia Moreno-Macías; Alicia Huerta-Chagoya; Claire Churchhouse; Carla Márquez-Luna; Humberto García-Ortíz; María José Gómez-Vázquez; Noël P Burtt; Carlos A Aguilar-Salinas; Clicerio González-Villalpando; Jose C Florez; Lorena Orozco; Christopher A Haiman; Teresa Tusié-Luna; David Altshuler
Journal:  Nature       Date:  2013-12-25       Impact factor: 49.962

Review 5.  The molecular biology of head and neck cancer.

Authors:  C René Leemans; Boudewijn J M Braakhuis; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2010-12-16       Impact factor: 60.716

6.  CK7 expression in carcinomas of the Waldeyer's ring area.

Authors:  S Regauer; A Beham; S Mannweiler
Journal:  Hum Pathol       Date:  2000-09       Impact factor: 3.466

7.  Decreased expression of E-cadherin and Yamamoto-Kohama's mode of invasion highly correlates with lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  T Kaihara; T Kusaka; H Kawamata; Y Oda; S Fujii; K Morita; J Imura; T Fujimori
Journal:  Pathobiology       Date:  2001       Impact factor: 4.342

8.  Guidelines for the welfare and use of animals in cancer research.

Authors:  P Workman; E O Aboagye; F Balkwill; A Balmain; G Bruder; D J Chaplin; J A Double; J Everitt; D A H Farningham; M J Glennie; L R Kelland; V Robinson; I J Stratford; G M Tozer; S Watson; S R Wedge; S A Eccles
Journal:  Br J Cancer       Date:  2010-05-25       Impact factor: 7.640

9.  T cell-independent modulation of experimental autoimmune encephalomyelitis in ADAP-deficient mice.

Authors:  Swen Engelmann; Mauro Togni; Anja Thielitz; Peter Reichardt; Stefanie Kliche; Dirk Reinhold; Burkhart Schraven; Annegret Reinhold
Journal:  J Immunol       Date:  2013-10-07       Impact factor: 5.422

10.  Establishment and identification of human primary lung cancer cell culture in vitro.

Authors:  Lian-Lian Si; Lu Lv; Wen-Hui Zhou; Wei-Dong Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
View more
  3 in total

Review 1.  Perspectives of Immune Suppression in the Tumor Microenvironment Promoting Oral Malignancy.

Authors:  Nobuo Kondoh; Masako Mizuno-Kamiya; Eiji Takayama; Harumi Kawati; Naoki Umemura; Yutaka Yamazaki; Kenji Mitsudo; Iwai Tohnai
Journal:  Open Dent J       Date:  2018-06-20

Review 2.  Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer.

Authors:  Wei-Chiao Chiu; Da-Liang Ou; Ching-Ting Tan
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

Review 3.  Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma.

Authors:  Qiang Li; Heng Dong; Guangwen Yang; Yuxian Song; Yongbin Mou; Yanhong Ni
Journal:  Front Oncol       Date:  2020-02-25       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.